XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://xconomy.com/san-francisco/2018/10/31/to-boost-cancer-pipeline-gilead-bets-at-least-50m-on-startup-tango/60%Monthly2018-10-31 16:33
https://xconomy.com/san-francisco/2018/10/31/twist-bioscience-ipo-hauls-in-70m-for-dna-synthesis-technology/60%Monthly2018-10-31 16:26
https://xconomy.com/detroit-ann-arbor/2018/10/31/teraki-using-edge-processing-to-meet-exploding-data-demands-of-avs/60%Monthly2018-10-31 16:24
https://xconomy.com/texas/2018/10/31/sams-club-goes-digital-bnsfs-electric-locomotive-more-tx-tech/60%Monthly2019-01-29 06:50
https://xconomy.com/boston/2018/10/31/moonshots-tough-tech-and-not-falling-in-love-with-your-robot/60%Monthly2018-10-31 13:11
https://xconomy.com/boston/2018/10/31/orchard-fueled-by-gsks-ex-gene-therapy-biz-nets-200m-in-ipo/60%Monthly2018-10-31 13:10
https://xconomy.com/san-francisco/2018/10/30/facebooks-3q-growth-suffices-to-stave-off-another-stock-dive/60%Monthly2018-10-31 03:19
https://xconomy.com/san-diego/2018/10/30/cfo-todd-young-leaving-acadia-pharmaceuticals/60%Monthly2018-10-31 13:25
https://xconomy.com/texas/2018/10/30/mr3-health-takes-aim-at-foot-ulcers-as-san-antonio-tackles-diabetes/60%Monthly2018-10-30 19:57
https://xconomy.com/san-diego/2018/10/30/fundraising-startup-classy-surpasses-1b-raised-on-its-platform/60%Monthly2018-10-31 16:39
https://xconomy.com/san-francisco/2018/10/30/harpoon-therapeutics-adds-holger-wesche-georgia-erbez-to-c-suite/60%Monthly2018-10-30 23:09
https://xconomy.com/new-york/2018/10/30/former-celgene-exec-goncalves-joins-cara-as-chief-medical-officer/60%Monthly2018-10-30 16:12
https://xconomy.com/boston/2018/10/30/a-i-cybersecurity-the-changing-face-of-vc-at-x%c2%b7con-next-week/60%Monthly2018-10-30 13:22
https://xconomy.com/boston/2018/10/30/fda-blasts-data-trial-design-for-alkermes-depression-drug/60%Monthly2018-10-30 16:04
https://xconomy.com/national/2018/10/29/stantt-ceo-thinks-its-approach-to-selling-mens-wear-fits-just-right/60%Monthly2018-10-31 16:07
https://xconomy.com/boston/2018/10/29/as-midterms-approach-notarize-lends-a-hand-to-absentee-voters-in-sd/60%Monthly2018-10-30 18:17
https://xconomy.com/boston/2018/10/29/pre-existing-immunity-to-crispr-found-in-96-of-people-in-study/60%Monthly2018-10-30 16:16
https://xconomy.com/detroit-ann-arbor/2018/10/29/no-pipeline-problem-backstage-capitals-detroit-plans-spark-excitement/60%Monthly2018-10-29 19:44
https://xconomy.com/new-york/2018/10/29/ibm-buying-red-hat-in-34b-mega-deal-to-beat-amazon-google-in-cloud/60%Monthly2018-10-29 17:38
https://xconomy.com/boston/2018/10/29/free-of-baggage-dicerna-cuts-another-rnai-deal-and-gets-200m/60%Monthly2018-10-29 15:03
https://xconomy.com/san-diego/2018/10/26/cuida-health-launches-voice-based-social-wellness-app-for-seniors/60%Monthly2018-10-27 00:12
https://xconomy.com/new-york/2018/10/26/melinta-chief-exec-wechsler-steps-down-johnson-named-interim-ceo/60%Monthly2018-10-29 20:10
https://xconomy.com/boston/2018/10/26/novartis-exec-mitchener-joins-axcella-as-chief-business-officer/60%Monthly2018-10-29 20:13
https://xconomy.com/national/2018/10/26/pineapples-and-bananas-yummy-to-eat-and-now-fashionable-to-wear/60%Monthly2018-10-26 20:58
https://xconomy.com/boston/2018/10/26/boston-tech-watch-scooter-regs-threat-stack-irobot-teikametrics/60%Monthly2018-10-26 17:45
https://xconomy.com/san-francisco/2018/10/26/u-k-slaps-maximum-fine-of-645000-on-facebook-for-privacy-violations/60%Monthly2018-10-26 11:44
https://xconomy.com/national/2018/10/26/bio-roundup-alzheimers-puzzle-esmo-assessed-drug-prices-more/60%Monthly2018-10-26 11:35
https://xconomy.com/san-diego/2018/10/25/startup-developing-opioid-alternative-takes-top-quick-pitch-honors/60%Monthly2018-10-26 18:37
https://xconomy.com/national/2018/10/25/trump-plan-ties-medicare-drug-prices-to-cheaper-foreign-ones/60%Monthly2018-10-25 21:43
https://xconomy.com/boston/2018/10/25/fresh-data-add-more-confusion-to-eisai-biogen-alzheimers-drug/60%Monthly2018-10-25 18:39
https://xconomy.com/san-francisco/2018/10/25/89bio-joins-nash-chase-with-a-teva-drug-and-65m-in-funding/60%Monthly2018-10-30 16:31
https://xconomy.com/texas/2018/10/25/delivery-robots-in-big-d-rodriguez-leaves-the-station-more-tx-tech/60%Monthly2018-10-25 19:08
https://xconomy.com/texas/2018/10/25/still-seeking-pharma-partner-phoenix-bio-adds-1m-in-angel-funding/60%Monthly2018-10-25 13:34
https://xconomy.com/boston/2018/10/25/robots-a-i-and-cybersecurity-hit-x%c2%b7con-at-google-on-nov-6/60%Monthly2018-10-25 13:02
https://xconomy.com/boston/2018/10/25/pursing-a-crazy-stupid-idea-photos-from-disruptors-in-boston/60%Monthly2018-10-25 15:44
https://xconomy.com/boston/2018/10/25/vertex-hums-along-as-abbvie-snatches-up-a-rivals-cf-drugs-for-45m/60%Monthly2018-10-25 12:56
https://xconomy.com/san-francisco/2018/10/25/berkeleys-skydeck-offers-chip-design-support-worth-millions-to-startups/60%Monthly2018-10-26 16:44
https://xconomy.com/boston/2018/10/25/in-e-commerce-marketing-race-privy-aims-to-democratize-online-tools/60%Monthly2019-01-29 05:37
https://xconomy.com/national/2018/10/24/amgen-slashes-cholesterol-drug-price-60-to-match-rival-regeneron/60%Monthly2018-10-25 04:30
https://xconomy.com/detroit-ann-arbor/2018/10/24/ford-mobility-news-self-driving-car-tests-in-d-c-avis-app-deal/60%Monthly2018-10-24 20:44
https://xconomy.com/boston/2018/10/24/machine-learning-firm-datarobot-gets-100m-to-automate-data-science/60%Monthly2018-10-24 20:27
https://xconomy.com/boston/2018/10/24/medisafe-to-get-paid-for-health-apps-performance/60%Monthly2018-10-24 16:25
https://xconomy.com/wisconsin/2018/10/24/eyeing-foxconn-manufacturing-gig-platform-factoryfix-expands-in-wi/60%Monthly2018-11-29 23:12
https://xconomy.com/san-francisco/2018/10/24/sangamo-exec-gary-lee-joins-senti-bio-as-chief-scientific-officer/60%Monthly2018-10-25 14:46
https://xconomy.com/boston/2018/10/24/astrazenecas-kevin-horgan-joins-seres-as-chief-medical-officer/60%Monthly2018-10-25 14:40
https://xconomy.com/detroit-ann-arbor/2018/10/24/u-m-celebrates-rise-in-inventions-licensing-and-spinout-startups/60%Monthly2018-10-24 16:38
https://xconomy.com/boston/2018/10/24/blockchain-startup-algorand-bags-62m-hires-fuze-logmein-execs/60%Monthly2019-02-22 19:14
https://xconomy.com/texas/2018/10/23/herdx-adds-5m-for-iot-system-to-help-farmers-track-livestock/60%Monthly2018-10-23 22:30
https://xconomy.com/san-diego/2018/10/23/neogenomics-buys-ex-novartis-cancer-lab-genoptix-for-125m-stock/60%Monthly2018-10-23 18:47
https://xconomy.com/national/2018/10/23/baubles-bling-swoonery-uses-tech-to-connect-shoppers-with-jewelry/60%Monthly2018-10-23 18:34
https://xconomy.com/san-diego/2018/10/23/mirati-shares-fall-on-new-data-for-lung-cancer-drug-combo/60%Monthly2018-10-23 20:41
https://xconomy.com/national/2018/10/23/esmo-18-precision-meds-breast-lung-and-more-from-the-cancer-front/60%Monthly2018-10-23 18:28
https://xconomy.com/indiana/2018/10/23/perq-raises-5-million-to-advance-digital-guided-shopping-platform/60%Monthly2018-10-23 10:00
https://xconomy.com/boston/2018/10/23/with-90m-round-stoke-eyes-a-spinraza-for-epilepsy-and-a-2019-ipo/60%Monthly2018-10-23 10:04
https://xconomy.com/san-francisco/2018/10/23/why-technology-alone-wont-fix-education/60%Monthly2019-01-29 02:11
https://xconomy.com/san-francisco/2018/10/22/tech-industry-lobby-proposes-data-privacy-laws-critics-call-them-weak/60%Monthly2018-10-23 02:01
https://xconomy.com/texas/2018/10/22/european-business-services-company-may-open-u-s-hq-in-san-antonio/60%Monthly2018-10-22 19:34
https://xconomy.com/boston/2018/10/22/centrexion-plans-ipo-to-bankroll-non-opioid-pain-drugs/60%Monthly2018-10-22 18:58
https://xconomy.com/boston/2018/10/22/techstars-edx-learnlaunch-join-xcon-program-nov-4-6/60%Monthly2018-10-22 14:32
https://xconomy.com/detroit-ann-arbor/2018/10/22/roundup-optimizerx-parabricks-urc-startup-detroit-acm-and-more/60%Monthly2018-10-22 12:50
https://xconomy.com/san-francisco/2018/10/22/google-launching-its-own-computer-science-courses-on-campuses/60%Monthly2019-01-29 02:11
https://xconomy.com/san-diego/2018/10/22/qpex-biopharma-launches-with-33m-to-tackle-drug-resistant-infections/60%Monthly2018-10-22 11:13
https://xconomy.com/new-york/2018/10/19/abeona-therapeutics-appoints-joao-siffert-chief-medical-officer/60%Monthly2018-10-19 22:08
https://xconomy.com/san-francisco/2018/10/19/former-gilead-exec-kitty-yale-named-akero-chief-development-officer/60%Monthly2018-10-19 22:03
https://xconomy.com/wisconsin/2018/10/19/invenra-madison-firm-developing-therapeutic-antibodies-adds-7-1m/60%Monthly2018-10-22 19:10
https://xconomy.com/boston/2018/10/19/boston-tech-watch-ibm-dataxu-accion-yottaa-coachup-more/60%Monthly2018-10-19 21:09
https://xconomy.com/boston/2018/10/19/entrepreneurs-thinking-inside-the-box/60%Monthly2018-10-19 15:00
https://xconomy.com/san-diego/2018/10/19/tp-therapeutics-names-new-ceo-gets-80m-more-for-cancer-drug-push/60%Monthly2018-11-27 20:20
https://xconomy.com/national/2018/10/19/bio-roundup-prices-on-tv-novartis-hearts-radio-warp-drives-end/60%Monthly2018-10-19 11:04
https://xconomy.com/boston/2018/10/19/logicbio-prices-ipo-below-range-raising-70m-to-test-gene-therapy/60%Monthly2018-10-19 10:38
https://xconomy.com/detroit-ann-arbor/2018/10/19/with-8m-in-new-capital-vayavision-refines-raw-data-fusion-for-avs/60%Monthly2018-10-18 21:17
https://xconomy.com/texas/2018/10/18/realsavvy-takes-2-5m-to-bring-real-estate-app-to-three-new-states/60%Monthly2018-10-18 22:28
https://xconomy.com/wisconsin/2018/10/18/exact-sciences-acquires-san-diego-lab-equipment-supplier-biomatrica/60%Monthly2018-10-18 21:30
https://xconomy.com/new-york/2018/10/18/xconomys-exome-presents-new-york-biotech-how-to-make-it-here/60%Monthly2018-10-18 18:13
https://xconomy.com/indiana/2018/10/18/novartis-buys-endocyte-for-2-1b-making-a-second-bet-on-radiotherapy/60%Monthly2018-10-18 14:44
https://xconomy.com/new-york/2018/10/18/a-year-early-merck-touts-good-kidney-cancer-news-to-push-rival-bms/60%Monthly2018-10-18 14:55
https://xconomy.com/boston/2018/10/18/abbvie-commits-100m-to-morphic-in-fibrosis-drug-rd-alliance/60%Monthly2018-10-18 14:01
https://xconomy.com/indiana/2018/10/18/after-950k-investment-codelicious-grows-collaborative-teaching-model/60%Monthly2018-10-17 19:36
https://xconomy.com/san-francisco/2018/10/17/post-ipo-chat-with-ceo-of-anaplan-as-its-trading-price-surge-holds/60%Monthly2018-10-18 13:15
https://xconomy.com/new-york/2018/10/17/nikes-jim-scholefield-jumps-to-merck-to-lead-digital-strategy/60%Monthly2018-10-18 20:21
https://xconomy.com/boston/2018/10/17/ziopharm-chief-medical-officer-francois-lebel-to-step-down/60%Monthly2018-10-17 22:01
https://xconomy.com/boston/2018/10/17/all-about-talent-takeaways-from-mits-1b-plan-to-lead-way-in-a-i/60%Monthly2018-10-17 20:03
https://xconomy.com/wisconsin/2018/10/17/wisconsin-insurance-software-firm-dynamis-sold-to-applied-systems/60%Monthly2018-10-17 18:30
https://xconomy.com/boston/2018/10/17/in-boston-paul-allen-aimed-to-boost-biosciences-tempo-of-discovery/60%Monthly2018-10-17 18:34
https://xconomy.com/national/2018/10/17/report-express-scripts-shuts-out-teva-migraine-drug-prefers-rivals/60%Monthly2018-10-17 21:00
https://xconomy.com/texas/2018/10/17/icon-snags-9m-for-tech-to-print-3d-homes-in-24-hours-for-4000/60%Monthly2018-10-17 15:40
https://xconomy.com/national/2018/10/17/spinraza-inventors-take-home-3m-breakthrough-prize-in-life-sciences/60%Monthly2018-10-17 15:43
https://xconomy.com/wisconsin/2018/10/17/startups-eh-latest-gener8tor-class-includes-2-canadian-companies/60%Monthly2018-10-17 14:30
https://xconomy.com/san-diego/2018/10/17/atyr-pharma-chief-scientific-officer-david-king-to-resign/60%Monthly2018-10-17 13:50
https://xconomy.com/san-francisco/2018/10/17/softbanks-arm-to-include-cybereason-security-services-in-iot-hub/60%Monthly2018-10-17 13:21
https://xconomy.com/san-diego/2018/10/17/citing-regulatory-uncertainty-origin-code-academy-to-close/60%Monthly2018-10-17 12:48
https://xconomy.com/boston/2018/10/16/andreessen-leads-300m-bet-on-devoted-healths-senior-care-approach/60%Monthly2018-10-16 22:52
https://xconomy.com/texas/2018/10/16/cyberfortress-plans-2019-launch-as-cyber-insurance-industry-grows/60%Monthly2019-09-25 18:28
https://xconomy.com/seattle/2018/10/16/paul-allens-contributions-went-far-beyond-microsoft-researchers-say/60%Monthly2018-10-17 15:42
https://xconomy.com/new-york/2018/10/16/eli-lillys-david-bleakman-joins-redpin-as-chief-scientific-officer/60%Monthly2018-10-16 20:30
https://xconomy.com/boston/2018/10/16/rheos-medicines-names-gad-soffer-chief-operating-officer/60%Monthly2018-10-16 20:20
https://xconomy.com/wisconsin/2018/10/16/stratatech-gets-26m-more-to-develop-skin-tissue-for-treating-burns/60%Monthly2018-10-16 19:00
https://xconomy.com/san-francisco/2018/10/16/warp-drives-odyssey-ends-with-a-buyout-to-revolution-not-sanofi/60%Monthly2018-10-16 16:58
https://xconomy.com/new-york/2018/10/16/tulerie-helps-users-dress-like-models-without-breaking-the-bank/60%Monthly2018-10-16 14:41
https://xconomy.com/boston/2018/10/16/after-net-neutrality-how-to-prepare-for-the-internets-new-reality/60%Monthly2018-10-16 04:43
https://xconomy.com/boston/2018/10/15/fidelitys-new-crypto-startup-could-spark-wall-street-investment/60%Monthly2018-10-15 23:25
https://xconomy.com/texas/2018/10/15/tx-tech-wrap-new-fundings-ojo-picks-up-wolfnet-new-oracle-startups/60%Monthly2018-10-15 19:39
https://xconomy.com/new-york/2018/10/15/former-amgen-exec-sersch-joins-mustang-bio-as-chief-medical-officer/60%Monthly2018-10-15 16:25
https://xconomy.com/boston/2018/10/15/rhythm-pharma-appoints-murray-stewart-chief-medical-officer/60%Monthly2018-10-15 21:28
https://xconomy.com/san-diego/2018/10/15/study-reflextion-health-virtual-therapy-system-reduces-rehab-costs/60%Monthly2018-10-16 21:27
https://xconomy.com/detroit-ann-arbor/2018/10/15/fusion-coolant-systems-snags-8m-series-c-plans-to-hit-go-button/60%Monthly2018-10-15 13:33
https://xconomy.com/national/2018/10/15/room-service-by-robot-and-other-ways-tech-is-changing-the-hotel-stay/60%Monthly2018-10-15 18:51
https://xconomy.com/boston/2018/10/15/mit-raises-650m-for-new-college-to-advance-a-i-with-eye-on-ethics/60%Monthly2018-10-15 18:47
https://xconomy.com/boston/2018/10/15/alnylam-wont-seek-quick-fda-nod-for-second-rnai-drug/60%Monthly2018-10-15 12:33
https://xconomy.com/boston/2018/10/15/roche-and-sqz-biotech-expand-rd-pact-in-pursuit-of-new-cancer-drugs/60%Monthly2018-10-15 04:22
https://xconomy.com/wisconsin/2018/10/12/ahead-of-warf-keynote-gigaoms-reese-talks-academias-startup-push/60%Monthly2019-01-29 05:37
https://xconomy.com/wisconsin/2018/10/12/zendesk-moves-into-new-madison-office-with-room-for-400-employees/60%Monthly2018-10-12 19:46
https://xconomy.com/texas/2018/10/12/energy-real-estate-other-firms-pledge-capital-to-hx-venture-fund/60%Monthly2018-10-12 17:06
https://xconomy.com/san-diego/2018/10/12/ansun-biopharma-adds-stanley-lewis-to-c-suite/60%Monthly2018-10-12 16:43
https://xconomy.com/new-york/2018/10/12/bristol-stumbles-in-lung-cancer-again-as-rivals-play-catch-up/60%Monthly2018-10-12 17:26
https://xconomy.com/san-francisco/2018/10/12/adynxx-agrees-to-merger-with-alliqua-to-gain-public-stock-listing/60%Monthly2018-10-12 14:39
https://xconomy.com/national/2018/10/12/bio-roundup-bio-diversity-allogene-ipo-crispr-in-utero-more/60%Monthly2019-01-29 02:53
https://xconomy.com/detroit-ann-arbor/2018/10/12/reuters-report-ranks-u-m-among-worlds-most-innovative-universities/60%Monthly2018-10-11 19:11
https://xconomy.com/boston/2018/10/12/transatomic-power-leader-talks-startups-demise-political-headwinds/60%Monthly2019-01-29 06:50
https://xconomy.com/san-francisco/2018/10/11/facebook-bars-800-fake-accounts-and-pages-for-using-tactics-like-russias/60%Monthly2018-10-12 12:56
https://xconomy.com/national/2018/10/11/bio-has-big-diversity-goals-does-it-have-the-means-to-reach-them/60%Monthly2018-11-28 21:04
https://xconomy.com/boston/2018/10/11/tim-berners-lee-building-inrupt-to-fix-the-web-will-users-come/60%Monthly2018-10-11 17:48
https://xconomy.com/boston/2018/10/11/special-day-passes-for-x%c2%b7con-2018-november-4-5-and-6/60%Monthly2018-10-11 13:08
https://xconomy.com/detroit-ann-arbor/2018/10/11/planes-drones-automobiles-techstars-grads-run-the-mobility-gamut/60%Monthly2019-01-29 06:39
https://xconomy.com/boston/2018/10/11/xconomy-awards-2018-gala-honors-the-best-of-boston-life-science-slideshow/60%Monthly2018-10-12 05:50
https://xconomy.com/san-francisco/2018/10/11/allogenes-ipo-raises-288m-for-tests-of-off-the-shelf-cell-therapy/60%Monthly2018-10-11 10:50
https://xconomy.com/san-diego/2018/10/11/teradata-moves-to-san-diego-in-global-rebranding-effort/60%Monthly2018-10-11 11:51
https://xconomy.com/wisconsin/2018/10/10/swabbing-dna-on-phones-reveals-mysteries-of-microbial-world-around-us/60%Monthly2018-10-11 15:26
https://xconomy.com/san-francisco/2018/10/10/anaplan-ups-estimate-for-its-ipo-haul-allogene-ipo-tops-its-price-range/60%Monthly2018-10-11 00:01
https://xconomy.com/indiana/2018/10/10/biocrossroads-unveils-new-9m-seed-fund-for-biotech-agbio-startups/60%Monthly2018-10-10 23:21
https://xconomy.com/texas/2018/10/10/san-antonios-bioaffinity-signs-licensing-deal-for-cancer-diagnostic/60%Monthly2018-10-11 16:00
https://xconomy.com/boston/2018/10/10/crispr-therapeutics-vertex-get-fda-green-light-for-sickle-cell-test/60%Monthly2018-10-11 15:23
https://xconomy.com/san-diego/2018/10/10/with-vernalis-buy-ligand-adds-to-portfolio-establishes-u-k-presence/60%Monthly2018-10-10 20:36
https://xconomy.com/wisconsin/2018/10/10/understory-nabs-6-5m-to-expand-network-of-weather-tracking-stations/60%Monthly2019-03-05 01:11
https://xconomy.com/new-york/2018/10/10/contravir-names-robert-foster-acting-ceo-in-executive-shuffle/60%Monthly2018-10-11 22:38
https://xconomy.com/san-francisco/2018/10/10/harpoon-therapeutics-appoints-natalie-sacks-chief-medical-officer/60%Monthly2018-10-10 13:54
https://xconomy.com/new-york/2018/10/10/in-new-york-gotham-starts-up-with-54m-for-rna-modifying-drugs/60%Monthly2018-10-10 15:15
https://xconomy.com/boston/2018/10/10/boston-tech-watch-wayfair-monster-randori-rocket-cogito-more/60%Monthly2018-10-09 22:19
https://xconomy.com/boston/2018/10/09/passport-buys-austin-parking-enforcement-software-company-nupark/60%Monthly2019-01-29 06:36
https://xconomy.com/boston/2018/10/09/eying-nash-glympse-raises-22m-to-test-disease-detection-nanotech/60%Monthly2019-01-29 05:16
https://xconomy.com/national/2018/10/09/u-s-venture-capital-deals-on-pace-to-exceed-100b-in-2018/60%Monthly2018-10-11 02:11
https://xconomy.com/texas/2018/10/09/xenex-adds-4-8m-for-hospital-trial-program-of-germ-zapping-robots/60%Monthly2018-10-09 21:19
https://xconomy.com/san-francisco/2018/10/09/with-a-10-2m-boost-yourmechanic-aims-at-mobility-fleet-market/60%Monthly2018-10-09 20:37
https://xconomy.com/new-york/2018/10/08/click-therapeutics-adds-randall-kaye-austin-speier-to-c-suite/60%Monthly2018-10-08 21:52
https://xconomy.com/san-francisco/2018/10/08/ngm-biopharma-promotes-woodhouse-to-ceo-trombley-to-president/60%Monthly2018-10-08 21:44
https://xconomy.com/texas/2018/10/08/upland-software-bumble-in-india-cratejoy-layoffs-more-tx-tech/60%Monthly2018-10-08 16:38
https://xconomy.com/san-francisco/2018/10/08/menlos-drug-fails-again-in-clinical-trials-this-time-chronic-cough/60%Monthly2018-10-08 15:10
https://xconomy.com/detroit-ann-arbor/2018/10/08/new-vari-initiative-aims-to-understand-how-metabolism-drives-disease/60%Monthly2018-10-08 12:53
https://xconomy.com/boston/2018/10/08/circulation-ceo-talks-sale-to-logisticare-amazons-healthcare-play/60%Monthly2018-10-09 14:09
https://xconomy.com/texas/2018/10/08/incube-velocitytx-join-work-to-develop-pediatric-medical-devices/60%Monthly2018-10-05 19:19
https://xconomy.com/san-diego/2018/10/05/senomyx-maker-of-flavor-enhancers-set-to-be-acquired-by-firmenich/60%Monthly2018-10-06 03:02
https://xconomy.com/boston/2018/10/05/fda-oks-akcea-rare-disease-drug-setting-up-market-clash-with-alnylam/60%Monthly2018-10-08 21:59
https://xconomy.com/texas/2018/10/05/houston-software-developer-seeks-to-raise-voter-turnout-with-chatbot/60%Monthly2018-10-05 19:04
https://xconomy.com/san-diego/2018/10/05/genomatica-grabs-90m-to-boost-sustainable-chemical-business/60%Monthly2019-01-29 06:50
https://xconomy.com/boston/2018/10/05/sqz-biotech-appoints-pfizer-veteran-volker-herrmann-coo/60%Monthly2018-10-08 18:14
https://xconomy.com/san-francisco/2018/10/05/bioclin-chairman-scott-myers-adds-ceo-role/60%Monthly2018-10-08 18:20
https://xconomy.com/boston/2018/10/05/with-orchards-ipo-gsks-old-gene-therapy-biz-gets-a-wall-street-test/60%Monthly2018-10-05 14:10
https://xconomy.com/boston/2018/10/05/schneider-electric-leads-18m-round-for-home-energy-startup-sense/60%Monthly2019-01-29 06:51
https://xconomy.com/national/2018/10/05/bio-roundup-nobel-prizes-sarepta-gene-therapy-guardant-ipo-more/60%Monthly2018-10-05 11:17
https://xconomy.com/indiana/2018/10/04/onecause-snags-4m-investment-plans-to-expand-fundraising-platform/60%Monthly2018-10-05 18:57
https://xconomy.com/wisconsin/2018/10/04/janssen-reaches-250m-deal-for-rights-to-arrowheads-hep-b-rnai-drug/60%Monthly2018-10-04 20:04
https://xconomy.com/san-francisco/2018/10/04/fda-approves-roche-drug-for-all-hemophilia-a-patients-but-rivals-loom/60%Monthly2018-10-05 16:48
https://xconomy.com/san-francisco/2018/10/04/guardant-healths-ipo-tops-range-raising-238m-for-cancer-tests/60%Monthly2018-10-04 14:44
https://xconomy.com/boston/2018/10/04/rethink-robotics-maker-of-factory-robots-shuts-down-reports/60%Monthly2018-10-04 13:54
https://xconomy.com/boston/2018/10/04/climacell-grabs-45m-for-weather-data-for-airlines-driverless-cars/60%Monthly2018-10-03 21:47
https://xconomy.com/san-francisco/2018/10/03/cloudera-hortonworks-plan-to-merge-as-5-2b-cloud-data-platform/60%Monthly2018-10-04 21:51
https://xconomy.com/san-francisco/2018/10/03/second-genome-promotes-karim-dabbagh-to-president-ceo/60%Monthly2018-10-03 22:17
https://xconomy.com/seattle/2018/10/03/pfizers-bernard-fermini-joins-novoheart-as-chief-rd-officer/60%Monthly2018-10-03 22:08
https://xconomy.com/boston/2018/10/03/sarepta-touts-new-data-and-benefit-signal-with-duchenne-gene-therapy/60%Monthly2018-10-04 17:22
https://xconomy.com/san-diego/2018/10/03/rady-childrens-to-test-bay-area-startups-diagnostics-tool-for-cns/60%Monthly2018-10-03 20:30
https://xconomy.com/boston/2018/10/03/paratek-pharma-wins-two-fda-approvals-for-three-conditions-in-same-day/60%Monthly2018-10-03 19:54
https://xconomy.com/detroit-ann-arbor/2018/10/03/honda-invests-2-75-billion-in-cruise-gms-driverless-car-subsidiary/60%Monthly2018-10-05 19:04
https://xconomy.com/seattle/2018/10/03/apptio-acquires-fittedcloud-to-broaden-enterprise-it-analytics-tools/60%Monthly2019-01-29 02:29
https://xconomy.com/texas/2018/10/03/idonate-raises-millions-to-help-its-nonprofit-customers-do-the-same/60%Monthly2018-10-03 17:29
https://xconomy.com/boston/2018/10/03/hopper-reels-in-100m-to-boost-travel-booking-app/60%Monthly2018-10-03 13:59
https://xconomy.com/national/2018/10/03/super-saver-rate-for-san-francisco-biotech-event-ends-tomorrow/60%Monthly2018-10-02 16:29
https://xconomy.com/san-francisco/2018/10/03/girls-in-tech-showcases-women-founders-in-sf-pitch-competition/60%Monthly2018-10-03 05:03
https://xconomy.com/boston/2018/10/02/synlogic-promotes-aoife-brennan-to-president-ceo/60%Monthly2018-10-02 21:24
https://xconomy.com/san-francisco/2018/10/02/oric-pharmaceuticals-names-pratik-multani-chief-medical-officer/60%Monthly2018-10-02 21:11
https://xconomy.com/texas/2018/10/02/tech-events-in-austin-houston-promote-women-founders-success/60%Monthly2018-10-03 21:40
https://xconomy.com/boston/2018/10/02/elemental-lands-partnership-with-perkinelmer-plus-9m-in-vc-bucks/60%Monthly2018-10-03 17:39
https://xconomy.com/san-francisco/2018/10/02/pivot-bio-gets-70m-led-by-bill-gatess-fund-to-replace-fertilizer/60%Monthly2018-10-02 04:52
https://xconomy.com/wisconsin/2018/10/01/madison-startup-asto-ct-raises-1-1m-for-large-animal-imaging-device/60%Monthly2019-03-05 01:11
https://xconomy.com/national/2018/10/01/fdas-latest-cancer-approval-underscores-immunotherapy-nobel-prize/60%Monthly2018-10-04 19:10
https://xconomy.com/san-diego/2018/10/01/10-san-diego-startups-to-compete-at-regions-top-pitch-competition/60%Monthly2018-10-01 19:07
https://xconomy.com/texas/2018/10/01/conversable-impact-hub-data-world-localeur-acc-more-tx-tech/60%Monthly2018-10-03 13:18
https://xconomy.com/national/2018/10/01/nobel-medicine-prize-honors-cancer-immunotherapy-pioneers-allison-honjo/60%Monthly2018-10-01 20:09
https://xconomy.com/new-york/2018/10/01/albert-bourla-named-successor-to-ian-read-as-pfizer-ceo/60%Monthly2018-10-01 18:38
https://xconomy.com/boston/2018/10/01/heres-the-agenda-for-x%c2%b7con-2018-on-nov-4-6-and-why-you-should-care/60%Monthly2018-10-02 15:55
https://xconomy.com/san-diego/2018/10/01/velosbio-emerges-with-58m-in-funding-to-steer-cancer-drugs-to-clinic/60%Monthly2018-10-01 14:15
https://xconomy.com/boston/2018/10/01/ge-abruptly-replaces-ceo-flannery-with-former-danaher-ceo/60%Monthly2019-01-29 06:51
https://xconomy.com/detroit-ann-arbor/2018/10/01/detroits-guardhat-snags-20m-series-a-for-industrial-iot-platform/60%Monthly2018-10-01 14:29
https://xconomy.com/texas/2018/10/01/austins-spanning-cloud-bought-by-kaseya-third-owner-since-2014/60%Monthly2018-09-28 19:13
https://xconomy.com/boston/2018/10/01/tugg-led-by-reddit-vet-plans-new-volunteer-in-residence-program/60%Monthly2018-09-30 21:23